COMPUTERIZED MEASUREMENT OF MK-801-ELICITED POPPING AND HYPERACTIVITY IN MICE

被引:26
作者
ROSSE, RB
MASTROPAOLO, J
SUSSMAN, DM
KOETZNER, L
MORN, CB
DEUTSCH, SI
机构
[1] DEPT VET AFFAIRS MED CTR,PSYCHIAT SERV,WASHINGTON,DC 20422
[2] GEORGETOWN UNIV,SCH MED,DEPT PSYCHIAT,WASHINGTON,DC
[3] COULBOURN INSTRUMENTS,ALLENTOWN,PA
关键词
MK-801; PHENCYCLIDINE; PSYCHOSIS; POPPING; MOUSE;
D O I
10.1097/00002826-199510000-00008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
MK-801, a high-affinity phencyclidine (PCP) analogue, is a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) subclass of glutamate receptor that elicits hyperactivity, stereotypic behaviors, and ''popping,'' an explosive episodic jumping behavior, in mice. The schizophreniform psychosis precipitated by PCP in humans has stimulated interest in studying MK-801-elicited mouse behaviors for their potential development as animal models of idiopathic psychosis. We describe a computerized method for measuring popping and hyperactivity elicited by MK-801 in mice, based on vertical displacements of a platform. This computerized procedure allows for the automatic measurement of discrete ''pops'' per individual episode of popping behavior, the force of each one of the explosive jumps, and the duration of discrete episodes of popping; these latter measures could not be easily ascertained by visual inspection alone. Moreover, the computerized measurements facilitate quantitative evaluation of the effects of pharmacological manipulations on MK-801-elicited popping, For example, the antipsychotic haloperidol was shown to reduce significantly both MK-801-induced popping and hyperactivity. Ideally, MK-801-elicited mouse popping and hyperactivity will serve as a useful preclinical screening paradigm for potential antipsychotic medications. Additionally, it is hoped that the use of this automated system will contribute to a greater understanding of the mechanisms of MK-801-induced popping and hyperactivity.
引用
收藏
页码:448 / 457
页数:10
相关论文
共 14 条
[1]   THE GLYCINE NMDA RECEPTOR ANTAGONIST, R-(+)-HA-966, BLOCKS ACTIVATION OF THE MESOLIMBIC DOPAMINERGIC SYSTEM INDUCED BY PHENCYCLIDINE AND DIZOCILPINE (MK-801) IN RODENTS [J].
BRISTOW, LJ ;
HUTSON, PH ;
THORN, L ;
TRICKLEBANK, MD .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (04) :1156-1163
[2]   WHEN SYMPTOMS PERSIST - CHOOSING AMONG ALTERNATIVE SOMATIC TREATMENTS FOR SCHIZOPHRENIA [J].
CHRISTISON, GW ;
KIRCH, DG ;
WYATT, RJ .
SCHIZOPHRENIA BULLETIN, 1991, 17 (02) :217-245
[3]   A GLUTAMATERGIC HYPOTHESIS OF SCHIZOPHRENIA - RATIONALE FOR PHARMACOTHERAPY WITH GLYCINE [J].
DEUTSCH, SI ;
MASTROPAOLO, J ;
SCHWARTZ, BL ;
ROSSE, RB ;
MORIHISA, JM .
CLINICAL NEUROPHARMACOLOGY, 1989, 12 (01) :1-13
[4]   MEASUREMENT OF AN EXPLOSIVE BEHAVIOR IN THE MOUSE, INDUCED BY MK-801, A PCP ANALOG [J].
DEUTSCH, SI ;
HITRI, A .
CLINICAL NEUROPHARMACOLOGY, 1993, 16 (03) :251-257
[5]   BW234U, (CIS-9-[3-(3,5-DIMETHYL-1-PIPERAZINYL)PROPYL]CARBAZOLE DIHYDROCHLORIDE) - A NOVEL ANTIPSYCHOTIC AGENT [J].
FERRIS, RM ;
HARFENIST, M ;
MCKENZIE, GM ;
COOPER, B ;
SOROKO, FE ;
MAXWELL, RA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (06) :388-390
[6]   DIFFERENTIATION BETWEEN MK-801-INDUCED AND APOMORPHINE-INDUCED STEREOTYPED BEHAVIORS IN MICE [J].
HITRI, A ;
OCONNOR, DA ;
COHEN, JM ;
KEULER, DJ ;
DEUTSCH, SI .
CLINICAL NEUROPHARMACOLOGY, 1993, 16 (03) :220-236
[7]  
JAVITT DC, 1994, AM J PSYCHIAT, V151, P1234
[8]  
JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301
[9]   PROSPECTS FOR CLINICALLY TOLERATED NMDA ANTAGONISTS - OPEN-CHANNEL BLOCKERS AND ALTERNATIVE REDOX STATES OF NITRIC-OXIDE [J].
LIPTON, SA .
TRENDS IN NEUROSCIENCES, 1993, 16 (12) :527-532
[10]   THE MECHANISM OF ACTION OF NOVEL ANTIPSYCHOTIC-DRUGS [J].
MELTZER, HY .
SCHIZOPHRENIA BULLETIN, 1991, 17 (02) :263-287